Strategies involved in developing an effective vaccine for EBV-associated diseases.
Moss
D J
DJ
The Queensland Institute of Medical Research, The Bancroft Centre, Herston, Australia.
Schmidt
C
C
Elliott
S
S
Suhrbier
A
A
Burrows
S
S
Khanna
R
R
D015967:Gene Expression Regulation, Viral; D006566:Herpesviridae Infections / Q000517:prevention & control*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000502:physiology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014412:Tumor Virus Infections / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology*; D014779:Virus Replication
D016169:Lymphocyte Function-Associated Antigen-1; D014765:Viral Vaccines; D018799:Intercellular Adhesion Molecule-1